Rugby Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 0536-1279

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rugby Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 0536-1279). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Rugby Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride 5 mg/120 mg extended-release tablets packaging label. The label highlights that the product is an antihistamine and nasal decongestant for allergy and congestion relief with 12-hour effects. It includes the Rugby logo, dosage form, strength, and a depiction of the actual tablet size. The label also mentions comparison to Zyrtec-D active ingredients and states it is manufactured by Rugby Laboratories.*

FDA Label Image

Image 02

Drug Facts label for Rugby Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride extended-release tablets. It includes active ingredients, uses, warnings, precautions, directions for use by age groups, storage instructions, inactive ingredients, and customer support contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.